GHK-Cu skincare research roundup: what we actually know in 2026
Copper peptides have a long research history. Here is the plain-English version.
by Editorial team
A quick history
GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper) was first identified in human plasma in the 1970s. Levels decline with age, which is part of why it's been a long-running interest for aging-skin research.
What the evidence supports
Topical use has the strongest evidence base. Multiple small clinical studies show improvements in skin firmness, fine line appearance, and texture over 8 to 12 weeks of consistent topical application.
Mechanistically, GHK-Cu appears to support collagen and elastin signaling and to modulate copper-dependent enzymes involved in repair.
What is overstated
Injectable GHK-Cu for systemic 'anti-aging' has thin human evidence. Most claims extrapolate from cell or animal work that doesn't necessarily translate.
Hair regrowth claims are a popular marketing angle but rest on a small number of underpowered studies.
Practical notes
If you try a topical, patch-test first. Copper peptides can be reactive at high concentrations. Look for formulations between 0.05% and 2%, and avoid combining with strong acids in the same routine.